Journal of Clinical Apheresis

Article	Citations
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue	71
Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19	27
Convalescent plasma therapy in patients with COVID‐19	24
Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA‐associated vasculitis	23
Efficacy of convalescent plasma therapy for COVID‐19: A systematic review and meta‐analysis	18
The role of double filtration plasmapheresis in hypertriglyceridemic pancreatitis: A propensity score matching analysis	16
Ninety days transplant free survival with high volume plasma exchange in Wilson disease presenting as acute liver failure	16
Refractory vaccine‐induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE)	15
Unstimulated apheresis for chimeric antigen receptor manufacturing in pediatric/adolescent acute lymphoblastic leukemia patients	13
The use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease 2019: A critical appraisal of the current evidence	13
Red blood cell exchange to avoid intubating a COVID‐19 positive patient with sickle cell disease?	13
Anti‐MDA‐5 antibody‐positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease treated with therapeutic plasma exchange: A case series	13
A matched cohort study of convalescent plasma therapy for COVID‐19	12
Efficacy of therapeutic plasma exchange for treatment of autoimmune hemolytic anemia: A systematic review and meta‐analysis of randomized controlled trials	10
Therapeutic plasma exchange in acute on chronic liver failure	10
Special Issue Abstracts from the American Society for Apheresis 44th Annual Meeting April 26–28, 2023	10
Effect of TPE vs medical management on patient outcomes in the setting of hypertriglyceridemia‐induced acute pancreatitis with severely elevated triglycerides	10
Immune checkpoint inhibitor toxicity: A new indication for therapeutic plasma exchange?	10
Therapeutic plasma exchange for clinically amyopathic dermatomyositis (CADM) associated with rapidly progressive interstitial pneumonia	10
Rapid reduction in triglyceride levels by therapeutic plasma exchange in patients with hypertriglyceridemic pancreatitis	10
Immunoadsorption and plasma exchange—Efficient treatment options for neurological autoimmune diseases	10
Incidence, diagnosis, and outcome of immune‐mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura	9
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response	9
Parasite burden and red blood cell exchange transfusion for babesiosis	9
Efficacy of therapeutic plasma exchange in patients with Crimean‐Congo hemorrhagic fever	9

Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid‐resistant acute and chronic graft‐vs‐host disease after allogenic hematopoietic stem cell transplant	8
Therapeutic plasma exchange in a critically ill Covid‐19 patient	8
Protein spectrum changes in exosomes after therapeutic plasma exchange in patients with neuromyelitis optica	8
Vascular access for optimal hematopoietic stem cell collection	8
Ultrasound‐guidance of peripheral venous catheterization in apheresis minimizes the need for central venous catheters	8
Peripheral vascular access for therapeutic plasma exchange: A practical approach to increased utilization and selecting the most appropriate vascular access	7
Double‐blind, randomized controlled trial of therapeutic plasma exchanges vs sham exchanges in moderate‐to‐severe relapses of multiple sclerosis	7
Therapeutic plasma exchange with albumin as a valuable method of preparing thyrotoxic patients for a life‐saving thyroidectomy	7
Therapeutic plasma exchange for control of thyroid storm	7
Abstract	7
Initial experience with high‐volume plasma exchange in patients with acute liver failure	7
“Plasma exchange in a bottle”: An overview of efgartigimod for apheresis practitioners	6
Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group	6
Pilot study of a new online extracorporeal photopheresis system in patients with steroid refractory or dependent chronic graft vs host disease	6
Hemostatic effects of therapeutic plasma exchange: A concise review	6
Therapeutic plasma exchange and dextran‐sulfate plasma adsorption as extracorporeal treatments of extremely preterm preeclampsia with fetal growth restriction	6
Comparison of three modalities of plasmapheresis on coagulation: Centrifugal, single‐membrane filtration, and double‐filtration plasmapheresis	6
Plasmapheresis compared with conventional treatment for hypertriglyceridemia‐induced acute pancreatitis: A systematic review and meta‐analysis	6
Pyoderma gangrenosum in an ulcerative colitis patient during treatment with vedolizumab responded favorably to adsorptive granulocyte and monocyte apheresis	6
Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy	6
Potential differences between double‐filtration plasmapheresis and therapeutic plasma exchange in the treatment of acute hypertriglyceridemic pancreatitis	6
Double filtration plasmapheresis in hypertriglyceridemic pancreatitis: Triglyceride levels and clinical outcomes	5
Peripheral blood stem cell collection in children with extremely low body weight (≤8 kg). What have we learned over the past 25 years and where are the limits?	5
Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster‐randomized controlled trial	5
The ABC's of disaster management: Managing apheresis operations during the SARS‐CoV‐2 pandemic	5
Pediatric double positive anti‐glomerular basement membrane antibody and anti‐neutrophil cytoplasmic antibody glomerulonephritis—A case report with review of literature	5
Cardiovascular events in patients with familial hypercholesterolemia and hyperlipoproteinaemia (a): Indications for lipoprotein apheresis in Poland	5
Double‐filtration plasmapheresis combined with immunosuppressive treatment for severe pemphigus: 10 years' experience of a single center in China	5
Effect of immunoadsorption alone or combined with membrane filtration on hemostasis parameters	5
Source plasma deferral trends: A 3‐year analysis of 255 centers in the United States	5
Lipoprotein apheresis and PCSK9 inhibitors for severe familial hypercholesterolaemia: Experience from Australia and New Zealand	5
Role of extracorporeal photopheresis in the management of children with graft‐vs‐host disease	5
Description of parallel and sequential configurations for concurrent therapeutic plasma exchange and continuous kidney replacement therapy in adults	5
Apheresis medicine in the era of advanced telehealth technologies: An American Society for Apheresis position paper Part I: Understanding the basic technologies and apheresis medicine practice models	5
Treatment of refractory myasthenia gravis by double‐filtration plasmapheresis and rituximab: A case series of nine patients and literature review	5
Successful use of nonantigen‐specific immunoadsorption with antihuman Ig‐columns in kidney graft antibody‐mediated rejection	5
Development of iron deficiency anemia in patients undergoing extracorporeal photopheresis: Comparison of the UVAR and CELLEX instruments	5
How to write a manuscript for peer review	4
Membrane‐based therapeutic plasma exchange: Hemodynamics and operational characteristics leading to procedure failure	4
Tolerance and complications of therapeutic plasma exchange by centrifugation: A single center experience	4
Homozygous familial hypercholesterolemia with severe involvement of the aortic valve—A sibling‐controlled case study on the efficacy of lipoprotein apheresis	4
Lack of defined apheresis collection criteria in publicly available CAR‐T cell clinical trial descriptions: Comprehensive review of over 600 studies	4
The first pediatric case of hemophagocytic lymphohistiocytosis secondary to Crimean‐Congo haemorrhagic fever successfully treated with therapeutic plasma exchange accompanying ribavirin and	4
Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies	4
Trends in the use of therapeutic plasma exchange in multiple myeloma	4
A comparative study of five plateletpheresis machines in a tertiary care center of India: AmiCORE vs COM.TEC vs Haemonetics MCS+ vs Spectra Optia vs Trima A	4
Ultrasound‐based criteria for adequate peripheral venous access in therapeutic apheresis procedures	4
Use of therapeutic plasma exchange in heparin‐induced thrombocytopenia: A population‐based study	4
Safety and efficacy of plasma exchange via direct femoral vein puncture in autoimmune blistering diseases	4
Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center	4

Therapeutic plasma exchange is a safe and effective bridge therapy in patients with alcohol‐associated ACLF not having immediate prospects for liver transplantation—A case‐control, pilot st	4
Acquired factor XIII deficiency in patients under therapeutic plasma exchange: A poorly explored etiology	4
The role of therapeutic plasma exchange in clinically amyopathic dermatomyositis with MDA‐5 antibody: A case report and review of the literature	4
Analysis of laboratory parameters for optimal autologous peripheral blood stem cell collection from lymphoma and myeloma patients	4
Exogenous insulin antibody syndrome treated with plasma exchange after an incomplete response to immunosuppressive therapy	4
Retrospective comparison between COBE SPECTRA and SPECTRA OPTIA apheresis systems for hematopoietic progenitor cells collection for autologous and allogeneic transplantation in a single center	4
Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants	4
Comparison of spectra optia and amicus cell separators for autologous peripheral blood stem cell collection	4
Current state of therapeutic apheresis and cellular therapy education for transfusion medicine fellows in the United States	3
Adsorptive granulomonocytapheresis alters the gut bacterial microbiota in patients with active ulcerative colitis	3
Efficacy of peripheral arterial access for peripheral blood stem cells collection	3
A case of severe DRESS syndrome treated with therapeutic plasma exchange and intravenous immunoglobulin therapy	3
Analysis of 52 240 source plasma donors of convalescent COVID‐19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation	3
Autologous hematopoietic stem cell product contaminated with Salmonella due to occult salmonellosis in an asymptomatic donor	3
Peptide GAM immunoadsorption in anti‐PLA2R positive autoimmune membranous nephropathy. The PRISM trial	3
Efficacy of plasmapheresis and semi‐selective immunoadsorption for removal of anti‐HLA antibodies	3
Positive effects of ultrasound‐guided peripheral IV insertion on pediatric sickle cell anemia/thalassemia patients receiving automated red cell exchange procedures or chronic tra	3
Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura	3
Mobilized and apheresis‐collected endothelial progenitor cells with plerixafor	3
Plerixafor‐based mobilization in pediatric healthy donors with unfavorable donor/recipient body weight ratio resulted in a better CD34+ collection yield: A retrospective analysis	3
Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children	3
Apheresis medicine in the era of advanced telehealth technologies: An American Society for Apheresis position paper part II: Principles of apheresis medical practice in a 21st century electronic medic	3
Novel use of a midline catheter for therapeutic and donor apheresis in children and adults	3
Therapeutic plasmapheresis for the treatment of thyrotoxicosis: A retrospective multi‐center study	3
Terumo spectra optia leukapheresis of cynomolgus macaques for hematopoietic stem cell and T cell collection	3
Therapeutic thrombocytapheresis in myeloproliferative neoplasms: A single‐institution experience	3
Neonatal Fc receptor blockade as emerging therapy in diseases with plasma exchange indications	3
Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experience	3
Higher efficacy of intermediate dose cytarabine + G‐CSF compared to cyclophosphamide + G‐CSF in hematopoietic stem cell mobilization in patients with multiple myeloma	3
Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study	3
Rheopheresis for severe peripheral arterial disease in hemodialysis patients: A clinical series	3
Clinical experience with maintenance therapeutic plasma exchange in refractory generalized myasthenia gravis	3
Impact of the number of cryopreserved CD34+ cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation:	3
A strategy to conserve personal protective equipment while performing therapeutic plasma exchange in a patient with COVID‐19	3
Treatment of antibody‐mediated rejection with double‐filtration plasmapheresis, low dose IVIg plus rituximab after kidney transplantation	3
Severe complications in a 25‐year‐old male after brown recluse spider bite treated by therapeutic plasma exchange: A case report and review of other case studies	3
Infectious risks in patients treated with extracorporeal photopheresis for graft‐versus‐host disease: A retrospective cohort study	3
The role of treatment with plasma exchange therapy in two pediatric toxic epidermal necrolysis cases related to COVID‐19	3
ECP as additional immunomodulation in idiopathic hyperammonemia and recurrent hypercapnic respiratory failure early post lung transplantation	3
Efficacy of intravenous combined immunosuppression with plasmapheresis in adult patients with refractory primary focal segmental glomerulosclerosis	3
Therapeutic plasma exchange for peripheral neuropathy associated with trisulfated heparan disaccharide IgM antibodies: A case series of 17 patients	3
Therapeutic plasma‐exchange improves short‐term, but not long‐term, outcomes in patients with acute‐on‐chronic liver failure: A propensity score‐matched analysis	3
Immunogenic and immunotolerogenic effects of extracorporeal photopheresis in high immunological risk kidney recipients. A single center case series	2
Successful treatment with immunoadsorption therapy in four patients with severe and refractory anti‐N‐methyl‐D‐aspartate receptor encephalitis	2
Donor tolerability of convalescent plasma donation	2
Therapeutic plasma exchange for steroid refractory idiopathic inflammatory myopathies with interstitial lung disease	2
Are we choosing mobilization regimens for autologous stem cell transplantation in multiple myeloma wisely: A single center comparison of GCSF+/−plerixafor vs cyclophosphamide/GCSF	2
Use of dual lumen ports for red blood cell exchange: A comparison of adults and children with sickle cell disease	2
Therapeutic plasma exchange practices in immune thrombocytopenia related hospitalizations: Results from a nationally representative sample	2
Therapeutic plasma exchange: A potential therapeutic modality for critically ill adults with severe acute respiratory syndrome coronavirus 2 infection	2
Outcome of extracorporeal photopheresis in mycosis fungoides patients is not predicted by quotients of systemic immune‐inflammatory biomarkers	2
Successful treatment with therapeutic plasmapheresis of a pediatric patient with Guillain‐Barré syndrome associated with neurobrucellosis	2
Plerixafor added to G‐CSF allows mobilization of a sufficient number of hematopoietic progenitors without impacting the efficacy of TCR‐alpha/beta depletion in pediatric haploide	2
Immunoadsorption in a dog with severe immune mediated hemolytic anemia	2
Efficacy and safety of granulocyte transfusion in children: A single‐center experience	2
The report from ASFA COVID‐19 taskforce: Considerations and prioritization on apheresis procedures during the SARS‐CoV‐2 coronavirus disease (COVID‐19) pandemic	2
Correlation between peripheral blood automated hematopoietic progenitor cell counts and flow cytometric CD34+ cell counts differs according to diagnosis in patients undergoing au	2
Comparison of procedure times and collection efficiencies using integrated and multistep nonintegrated procedures for extracorporeal photopheresis	2
Central venous catheters are associated with thrombosis among adult inpatients undergoing therapeutic plasma exchange	2
Role of automated red blood cell exchange in the treatment of aluminum phosphide poisoning: A case report and review of the literature	2
Application of the French TMA Reference Center Score and the mortality in TTP Score in de novo and relapsed episodes of acquired thrombotic thrombocytopenic purpura at	2
Effect on haemostasis of different replacement fluids during therapeutic plasma exchange—A comparative multicentre observational study	2
Treatment of comatose patient from cyclobenzaprine overdose with therapeutic plasma exchange	2
Implications of CAR‐T cell therapy on apheresis services: a Scottish perspective	2
Is absence of CD56 a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma?	2
Efficacy and cost of double filtration plasmapheresis in severe hypertriglyceridemia‐induced pancreatitis: A retrospective observational study	2
Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation	2
Failure of double filtration plasmapheresis to treat severe pemphigus vulgaris: A case report	2
Use of therapeutic plasma exchange for pediatric neurological diseases	2
Nationwide practices in the use of central venous catheters for therapeutic plasma exchange in the inpatient setting	2
Addition of plerixafor in poorly mobilized allogeneic stem cell donors	2
Fibrinogen reconstitution after therapeutic apheresis: Comparison of double‐filtration plasmapheresis, plasma exchange, and immunoadsorption	2
A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naïve hereditary hemochromatosis	2
	2
The impact of delayed and immediate adverse events on the intention of future donations in whole blood and plateletpheresis donors	2
Assessing efficacy and safety of replacement fluids in therapeutic plasma exchange: A systematic scoping review of outcome measures used	2
The practical integration of a hybrid model of ultrasound‐guided peripheral venous access in a large apheresis center	2
Further evidence for the benefit of therapeutic plasma exchange for acute multi‐organ failure syndrome refractory to red cell exchange in sickle cell disease	2
	1
Mobilization with high‐dose granulocyte colony‐stimulating factor alone at 12 μg/kg twice a day in high‐risk pediatric patients: A retrospective analysis of the experience in a single center	1

Peripheral blood stem cells collection by apheresis in very low‐weight children with malignant diseases—A single center experience	1
No increase in anti‐A isohemagglutinin titer after SARS‐CoV‐2 infection: A retrospective cohort analysis of group O apheresis platelet donors	1
Total nucleated cell dose in graft is a better prognostic factor for survival in pediatric patients transplanted with bone marrow compared to CD34+, CD3+, or total mononuclear ce	1
	1
Regional citrate anticoagulation vs systemic heparin anticoagulation for double‐filtration plasmapheresis	1
Google Trends demonstrate public interest in COVID‐19 convalescent plasma therapy	1
Impact of saline infusion as replacement fluid at donor plasmapheresis	1
Efficient removal of antibodies to adeno‐associated viruses by immunoadsorption	1
Retrospective analysis comparing complication rates of centrifuge vs membrane‐based therapeutic plasma exchange in the pediatric population	1
Hematopoietic progenitor cell counting can optimize peripheral blood stem cell apheresis process	1
Cost comparison of extracorporeal photopheresis technologies at the European Institute of Oncology	1
Is a 20 gauge fenestrated intravenous catheter non‐inferior to a 18 gauge standard catheter for apheresis procedures? A pilot study	1
Botulism mimicking Guillain‐Barre syndrome: The question of plasma exchange in an unusual case of acute paralysis	1
Lessons relearned: Peripheral IV placement and recirculation	1
Extracorporeal photopheresis vs standard therapies for steroid‐refractory chronic graft‐vs‐host disease: Pharmacoeconomic assessment of hospital resource use in Spain	1
Therapeutic plasma exchange in a patient with acute motor axonal neuropathy subtype of Guillain‐Barre syndrome and systemic lupus erythematosus	1
Primed for change: The effect of a blood prime on peripheral blood stem cell collection and accuracy of a prediction tool in pediatric patients	1
Massive bee envenomation treated by therapeutic plasma exchange	1
Extracorporeal photopheresis and multimodality therapy in patients with T‐cell cutaneous lymphomas: Real‐life experience in Argentina	1
High D‐index during mobilization predicts poor mobilization ofCD34+ cells after anti‐lymphoma salvage chemotherapy	1
Posterior reversible encephalopathy syndrome associated with Guillain‐Barré syndrome: Case report and clinical management considerations	1
Impact of Covid‐19 on the therapeutic plasma exchange service within the South East Asian region: Consensus recommendations and global perspectives	1
Mathematical modeling of the impact of recirculation on exchange kinetics in tandem extracorporeal membrane oxygenation and therapeutic plasma exchange	1
A Saudi multicenter experience on therapeutic plasma exchange for patients with thrombotic thrombocytopenic purpura: A call for national registry	1
Safe peripheral blood stem cell collection in patients less than 10 kg: A single‐center review	1
Apheresis practice patterns in the United States of America: Analysis of a market claims database	1
Ethylene oxide‐type hypersensitivity reactions in G‐CSF mobilized, peripheral blood hematopoietic progenitor cell donors and review	1
Paradoxical embolic strokes in a liver transplant recipient with atrial septal defect undergoing therapeutic plasma exchange	1
Hyperchloremic metabolic acidosis after plasma exchange in a patient with renal transplant rejection: A case report	1
	1
Comparison of centrifugal and membrane filtration modalities on therapeutic plasma exchange	1
Algorithm‐based selection of automated red blood cell exchange procedure goals reduces blood utilization in chronically transfused adults with sickle cell disease	1
Impact of the CD4:CD8 ratio in bone marrow on stem cell mobilization and engraftment in autologous stem cell transplant patients	1
Comparison of hematopoietic progenitor cell collection using different inlet flow rates with the Fenwal Amicus	1
Writing scientific case reports for top‐line journals	1
Low‐density lipoprotein apheresis for recurrent focal segmental glomerulosclerosis post renal transplant in pediatric patients	1
A prospective study on tryptophan immunoadsorption in AQP4 antibody‐positive neuromyelitis optica spectrum disorders	1
What's in Your CART? Clinical insights on challenges in mononuclear cell collection for CAR‐T therapy	1
Rapid development of a de novo convalescent plasma program in response to a global pandemic: A large southeastern U.S. blood center's experience	1
A nationwide population‐based study on therapeutic plasma exchange for 10 years in Korea using Health Insurance Review and Assessment database	1
Apheresis Illustrated. Hyper‐triglyceridemic acute pancreatitis: A milky situation	1
An alternative procedure to leukapheresis for peripheral hematopoietic progenitor cell collection in very‐low‐weight children: A single pediatric center experience	1
Therapeutic plasma exchange in patients with severe obesity (BMI >40): A survey of practices in the United States	1
Successful “on‐demand” plerixafor for autologous peripheral blood stem‐cells transplantation for relapsed/refractory germ cell tumors	1
How to improve clotting factors depletion in double‐filtration plasmapheresis	1
Therapeutic plasma exchange for life‐threatening pediatric disorders	1
Establishing low‐density lipoprotein apheresis tolerability in patients with prior anaphylactoid reactions to lipoprotein apheresis using magnesium sulfate	1
A prospective comparison of pegfilgrastim and lipegfilgrastim combined with chemotherapy in the mobilization of CD34+ cells in NHL patients	1
Investigation on the feasibility of large‐volume autologous red blood cells donation: A pilot trial in a small cohort of Chinese	1
Efficacy and safety of adsorptive granulomonocytapheresis in Chinese patients with ulcerative colitis: A retrospective analysis of 50 cases with focus on factors impacting clinical efficacy	1
Feasibility and efficacy of low‐dose pegfilgrastim for CD34+ cell mobilization in lymphoma	1
COVID‐19 swab collection and serological screening in lipoprotein apheresis unit	1
Therapy plans for therapeutic apheresis in Epic HealthLink	1
The utility of therapeutic plasma exchange in Hyperviscosity syndrome associated with juvenile rheumatoid arthritis: A case report	1
COVID‐19‐associated transverse myelitis treated by therapeutic plasma exchange: A case report	1
Analysis of responses of the health care workers recovered from COVID‐19 on convalescent plasma donation by apheresis: A single‐center survey study	1
Two acute psychiatric emergencies and prevalence of mental health disorders at an outpatient apheresis clinic: Implications for apheresis practitioners	1
A new protocol for improving efficiency of autologous peripheral blood stem cell collection in patients with high white blood cell counts	1
Increased serum pro‐B‐type natriuretic peptide in hematopoietic progenitor cell donors stimulated with G‐CSF	1
Feasibility, safety, and tolerability of two modalities of plasma exchange with albumin replacement to treat elderly patients with Alzheimer's disease in the AMBAR study	1
Process mapping of the urgent red cell exchange procedure for patients with severe complications of sickle cell disease at a centralized hemapheresis service	1
Recovery of Symmetrical Peripheral Gangrene of Limbs in a Patient After Performing Hemoadsorption in Septic Shock	1
Surviving peer review	1
Safety and performance of theSpectraOptia apheresis system for white blood cell depletion in patients with elevated white blood cell counts	1
Pseudohemolysis during therapeutic plasma exchange due to IV iron dextran therapy	1
Successful stem cell collection for atypical teratoid rhabdoid tumor in an extremely low‐body weight child: A case report	1
Apheresis machines variably overestimate mononuclear cell collection volume	1
Role of prophylactic and therapeutic red blood cell exchange in pregnancy with sickle cell disease: Maternal and perinatal outcomes	1